Danimer Scientific, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Danimer Scientific's Q3 2024 results show a decrease in revenue and a net loss, alongside concerns about the company's ability to continue as a going concern.
Danimer Scientific's Q2 2024 results show a significant revenue decrease and a net loss, alongside strategic cost-cutting measures and a temporary suspension of a business segment.
Danimer Scientific's first quarter 2024 results show a decrease in overall revenue, but an increase in PHA-based product sales, alongside cost-cutting measures and strategic financial moves.